CN116270950A - Traditional Chinese medicine formula for treating diabetes - Google Patents
Traditional Chinese medicine formula for treating diabetes Download PDFInfo
- Publication number
- CN116270950A CN116270950A CN202310102011.XA CN202310102011A CN116270950A CN 116270950 A CN116270950 A CN 116270950A CN 202310102011 A CN202310102011 A CN 202310102011A CN 116270950 A CN116270950 A CN 116270950A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- solution
- chinese medicine
- treating diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 22
- 244000268590 Euryale ferox Species 0.000 claims abstract description 11
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 241000132012 Atractylodes Species 0.000 claims abstract description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 7
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 7
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 7
- 241000545744 Hirudinea Species 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 7
- 235000008397 ginger Nutrition 0.000 claims abstract description 7
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 7
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 5
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 5
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 5
- 244000197580 Poria cocos Species 0.000 claims abstract description 5
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 5
- 240000004980 Rheum officinale Species 0.000 claims abstract description 5
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 5
- 235000006533 astragalus Nutrition 0.000 claims abstract description 5
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 45
- 239000000843 powder Substances 0.000 claims description 37
- 239000010419 fine particle Substances 0.000 claims description 29
- 238000001914 filtration Methods 0.000 claims description 20
- 238000012216 screening Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000007888 film coating Substances 0.000 claims description 12
- 238000009501 film coating Methods 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- 230000002209 hydrophobic effect Effects 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 241000237903 Hirudo Species 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- 229920013820 alkyl cellulose Polymers 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 claims description 4
- 235000021552 granulated sugar Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 229940045860 white wax Drugs 0.000 claims description 4
- 241000050051 Chelone glabra Species 0.000 claims description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 2
- 229940107666 astragalus root Drugs 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims 2
- 244000247747 Coptis groenlandica Species 0.000 claims 1
- 244000299790 Rheum rhabarbarum Species 0.000 claims 1
- 230000006378 damage Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 230000003993 interaction Effects 0.000 abstract description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000033679 diabetic kidney disease Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023421 Kidney fibrosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 206010061989 glomerulosclerosis Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007119 pathological manifestation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of diabetes, and discloses a traditional Chinese medicine formula for treating diabetes, which comprises the following components in parts by weight: 10-20 parts of radix scutellariae, 10-12 parts of coptis chinensis, 20-25 parts of poria cocos, 15-20 parts of cinnamon, 10-20 parts of astragalus membranaceus, 8-10 parts of leech, 10-12 parts of a Heishan tablet, 10-15 parts of rheum officinale, 15-20 parts of bighead atractylodes rhizome, 15-20 parts of semen euryales, 10-15 parts of dried ginger and 15-20 parts of honey-fried licorice root. According to the traditional Chinese medicine formula for treating diabetes, in operation, through the interaction among traditional Chinese medicines, the residue of medicine amount is avoided, the side effect generated after a patient takes the medicine is reduced, the medicine is ensured to be absorbed completely, and the damage to the kidney of the patient is avoided.
Description
Technical Field
The invention belongs to the technical field of diabetes, and particularly relates to a traditional Chinese medicine formula for treating diabetes.
Background
Diabetes is a group of metabolic disorders syndrome of proteins, fat water and electrolytes, etc. caused by absolute or relative insufficient secretion of insulin and reduced sensitivity of target tissue cells to insulin, and a hyperglycemia is a major sign.
The mechanism of occurrence of diabetic kidney disease is currently unknown, and may be related to metabolic abnormality, hemodynamic disorder, inflammatory factor or inheritance, resulting in destruction of kidney function and structure, clinically manifested as albuminuria, edema, hypertension, renal insufficiency, etc., pathologically manifested as thickening of glomerular basement membrane and accumulation of extracellular matrix mainly in mesangial region, often accompanied with renal vascular, renal tubular interstitial lesions, eventually leading to glomerulosclerosis and renal interstitial fibrosis. The pathological manifestations are closely related to the progress of diabetic kidney disease.
However, most patients are treated by western medicines at present, and after the western medicines are taken, the residual medicine quantity is large, so that the patients can generate great side effects after taking the medicines, the medicines can not be completely absorbed, and the residual medicines cause damage to the kidneys of the patients.
Disclosure of Invention
In view of the above, in order to overcome the defects of the prior art, the invention provides a novel traditional Chinese medicine formula for treating diabetes, which utilizes traditional Chinese medicines to treat slowly, and effectively solves the problem that western medicines have more residues after being taken.
The invention is realized by the following technical scheme:
the traditional Chinese medicine formula for treating diabetes effectively solves the problems in the background technology.
In order to achieve the above purpose, the present invention provides the following technical solutions: a traditional Chinese medicine formula for treating diabetes comprises the following components in parts by weight: 10-20 parts of radix scutellariae, 10-12 parts of coptis chinensis, 20-25 parts of poria cocos, 15-20 parts of cinnamon, 10-20 parts of astragalus membranaceus, 8-10 parts of leech, 10-12 parts of a Heishan tablet, 10-15 parts of rheum officinale, 15-20 parts of bighead atractylodes rhizome, 15-20 parts of semen euryales, 10-15 parts of dried ginger and 15-20 parts of honey-fried licorice root.
Preferably, the preparation method of the formula comprises the following steps:
s1, crushing medicinal materials: adding Scutellariae radix, coptidis rhizoma, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix et rhizoma Rhei, atractylodis rhizoma, semen euryales, zingiberis rhizoma and radix Glycyrrhizae Preparata into a traditional Chinese medicine pulverizer, pulverizing, and sieving to obtain large-particle raw material powder and fine-particle raw material powder;
s2, repeatedly crushing: adding the large-particle raw material powder into the traditional Chinese medicine pulverizer again, passing through the screening device again, and repeating the operation until no large-particle powder appears;
s3, preparing a medicament: adding the fine particle powder into a heatable container, adding an aqueous solution into the heatable container, stirring the mixture to dissolve the fine particles, and heating the solution until the solution starts to boil;
s4, concentrating and filtering: adding the boiling solution into a concentrating device, controlling the pressure in the concentrating device, starting to pressurize the concentrating device until the volume of the solution in the concentrating device is reduced to half of the original volume, then introducing the solution in the concentrating device into a filtering device, filtering the solution, and filtering impurities in the solution to obtain the product.
Preferably, the screening device in S1 adopts multilayer oscillating screening, and the screen apertures of the multilayer screening are inconsistent, and the screen apertures of the multilayer screening are sequentially reduced from inside to outside.
Preferably, in the preparation of the medicament in S3, the fine particle powder needs to be weighed when the fine particle powder is added, the mass ratio of the fine particle powder to the water is 1:3, and when the water is added as the solvent, the fine particle powder needs to be added in three times, the hot water needs to be added for the first time and stirred, the dissolution of the fine particle powder is quickened, the warm water is added for the second time and stirred, the prepared medicament is diluted, and the normal-temperature aqueous solution is added for the third time, so that the dissolution efficiency of the medicament is increased.
Preferably, when the medicament is prepared in the step S3, after the solution starts to boil, the temperature is maintained and the stirring is performed, the duration is controlled to be 15-20 min, and granulated sugar is added into the boiled solution to increase the sweetness of the solution.
Preferably, after concentrating and filtering in the step S4, bottling the solution, and wrapping the inner wall of a bottling container with a hydrophobic film coating, wherein the hydrophobic film coating consists of alkyl cellulose, vinyl acetic acid polymeric derivatives, stearic acid film coating liquid and white wax oil.
Preferably, the step S1 is to pulverize the medicinal materials, and the prepared medicinal materials are as follows in parts by weight: 15 parts of baical skullcap root, 10 parts of coptis root, 20 parts of Indian buead, 18 parts of cassia bark, 10 parts of astragalus root, 8 parts of leech, 10 parts of Heishan tablet, 12 parts of rhubarb, 15 parts of largehead atractylodes rhizome, 16 parts of gorgon euryale seed, 12 parts of dried ginger and 15 parts of honey-fried licorice root.
Compared with the prior art, the invention has the beneficial effects that:
in operation, through the interaction between the traditional Chinese medicines, the medicine residue is avoided, the side effect generated after the patient takes the medicine is reduced, the medicine is ensured to be absorbed completely, and the damage to the kidney of the patient is avoided.
Drawings
The accompanying drawings are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate the invention and together with the embodiments of the invention, serve to explain the invention. In the drawings:
fig. 1 is a schematic flow chart of the traditional Chinese medicine formula.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and fully with reference to the accompanying drawings, in which it is evident that the embodiments described are only some, but not all embodiments of the invention; all other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
In the first embodiment, shown in fig. 1, a traditional Chinese medicine formula for treating diabetes is prepared from the following components in parts by weight: 15 parts of radix scutellariae, 10 parts of coptis chinensis, 20 parts of poria cocos, 18 parts of cinnamon, 10 parts of astragalus membranaceus, 8 parts of leech, 10 parts of black shun tablets, 12 parts of rheum officinale, 15 parts of bighead atractylodes rhizome, 16 parts of semen euryales, 12 parts of dried ginger and 15 parts of honey-fried licorice root;
a traditional Chinese medicine formula for treating diabetes mellitus, the preparation method of the formula comprises the following steps:
s1, crushing medicinal materials: adding Scutellariae radix, coptidis rhizoma, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix et rhizoma Rhei, atractylodis rhizoma, semen euryales, zingiberis rhizoma and radix Glycyrrhizae Preparata into a traditional Chinese medicine pulverizer, pulverizing, and sieving to obtain large-particle raw material powder and fine-particle raw material powder; the screening device in the S1 adopts multilayer vibration screening, the calibers of the screens of the multilayer screening are inconsistent, and the calibers of the screens of the multilayer screening are sequentially reduced from inside to outside;
s2, repeatedly crushing: adding the large-particle raw material powder into the traditional Chinese medicine pulverizer again, passing through the screening device again, and repeating the operation until no large-particle powder appears;
s3, preparing a medicament: adding the fine particle powder into a heatable container, adding an aqueous solution into the heatable container, stirring the mixture to dissolve the fine particles, and heating the solution until the solution starts to boil; when the medicament is prepared in the step S3, the fine particle powder needs to be weighed when the fine particle powder is added, the mass ratio of the fine particle powder to the water is ensured to be 1:3, when the water is added as a solvent, the water needs to be added for three times, hot water needs to be added for the first time and stirred, the dissolution of the fine particle powder is accelerated, warm water is added for the second time and stirred, the prepared medicament is diluted, and the normal-temperature aqueous solution is added for the third time, so that the dissolution efficiency of the medicament is improved; s3, when the medicament is prepared in the S3, after the solution starts to boil, keeping the temperature and stirring, controlling the duration to be 15-20 min, adding granulated sugar into the boiled solution, and increasing the sweetness of the solution;
s4, concentrating and filtering: adding the boiling solution into a concentrating device, controlling the pressure in the concentrating device, starting to pressurize the concentrating device until the volume of the solution in the concentrating device is reduced to half of the original volume, then introducing the solution in the concentrating device into a filtering device, filtering the solution, filtering impurities in the solution, bottling, concentrating and filtering in S4, bottling the solution, and wrapping a hydrophobic film coating on the inner wall of a bottling container, wherein the hydrophobic film coating consists of alkyl cellulose, vinyl acetic acid polymeric derivatives, stearic acid film coating liquid and white wax oil.
In the second embodiment, shown in fig. 1, a formula of a traditional Chinese medicine for treating diabetes is divided into the following components in parts by weight: 12 parts of radix scutellariae, 10 parts of coptis chinensis, 20 parts of poria cocos, 18 parts of cinnamon, 20 parts of astragalus mongholicus, 10 parts of leech, 12 parts of black shun tablets, 15 parts of rheum officinale, 20 parts of bighead atractylodes rhizome, 20 parts of semen euryales, 15 parts of dried ginger and 20 parts of honey-fried licorice root;
a traditional Chinese medicine formula for treating diabetes mellitus, the preparation method of the formula comprises the following steps:
s1, crushing medicinal materials: adding Scutellariae radix, coptidis rhizoma, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix et rhizoma Rhei, atractylodis rhizoma, semen euryales, zingiberis rhizoma and radix Glycyrrhizae Preparata into a traditional Chinese medicine pulverizer, pulverizing, and sieving to obtain large-particle raw material powder and fine-particle raw material powder; the screening device in the S1 adopts multilayer vibration screening, the calibers of the screens of the multilayer screening are inconsistent, and the calibers of the screens of the multilayer screening are sequentially reduced from inside to outside;
s2, repeatedly crushing: adding the large-particle raw material powder into the traditional Chinese medicine pulverizer again, passing through the screening device again, and repeating the operation until no large-particle powder appears;
s3, preparing a medicament: adding the fine particle powder into a heatable container, adding an aqueous solution into the heatable container, stirring the mixture to dissolve the fine particles, and heating the solution until the solution starts to boil; when the medicament is prepared in the step S3, the fine particle powder needs to be weighed when the fine particle powder is added, the mass ratio of the fine particle powder to the water is ensured to be 1:5, when the water is added as a solvent, the water needs to be added for three times, hot water needs to be added for the first time and stirred, the dissolution of the fine particle powder is accelerated, warm water is added for the second time and stirred, the prepared medicament is diluted, and the normal-temperature aqueous solution is added for the third time, so that the dissolution efficiency of the medicament is improved; s3, when the medicament is prepared in the S3, after the solution starts to boil, keeping the temperature and stirring, controlling the duration to be 20-30 min, adding granulated sugar into the boiled solution, and increasing the sweetness of the solution;
s4, concentrating and filtering: adding the boiling solution into a concentrating device, controlling the pressure in the concentrating device, starting to pressurize the concentrating device until the volume of the solution in the concentrating device is reduced to half of the original volume, then introducing the solution in the concentrating device into a filtering device, filtering the solution, filtering impurities in the solution, bottling, concentrating and filtering in S4, bottling the solution, and wrapping a hydrophobic film coating on the inner wall of a bottling container, wherein the hydrophobic film coating consists of alkyl cellulose, vinyl acetic acid polymeric derivatives, stearic acid film coating liquid and white wax oil.
It is noted that relational terms such as first and second, and the like are used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Moreover, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (7)
1. A traditional Chinese medicine formula for treating diabetes is characterized in that: the formula comprises the following components in parts by mass: 10-20 parts of radix scutellariae, 10-12 parts of coptis chinensis, 20-25 parts of poria cocos, 15-20 parts of cinnamon, 10-20 parts of astragalus membranaceus, 8-10 parts of leech, 10-12 parts of a Heishan tablet, 10-15 parts of rheum officinale, 15-20 parts of bighead atractylodes rhizome, 15-20 parts of semen euryales, 10-15 parts of dried ginger and 15-20 parts of honey-fried licorice root.
2. The traditional Chinese medicine formula for treating diabetes according to claim 1, which is characterized in that: the preparation method of the formula comprises the following steps:
s1, crushing medicinal materials: adding Scutellariae radix, coptidis rhizoma, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix et rhizoma Rhei, atractylodis rhizoma, semen euryales, zingiberis rhizoma and radix Glycyrrhizae Preparata into a traditional Chinese medicine pulverizer, pulverizing, and sieving to obtain large-particle raw material powder and fine-particle raw material powder;
s2, repeatedly crushing: adding the large-particle raw material powder into the traditional Chinese medicine pulverizer again, passing through the screening device again, and repeating the operation until no large-particle powder appears;
s3, preparing a medicament: adding the fine particle powder into a heatable container, adding an aqueous solution into the heatable container, stirring the mixture to dissolve the fine particles, and heating the solution until the solution starts to boil;
s4, concentrating and filtering: adding the boiling solution into a concentrating device, controlling the pressure in the concentrating device, starting to pressurize the concentrating device until the volume of the solution in the concentrating device is reduced to half of the original volume, then introducing the solution in the concentrating device into a filtering device, filtering the solution, and filtering impurities in the solution to obtain the product.
3. The traditional Chinese medicine formula for treating diabetes according to claim 1, which is characterized in that: the screening device in S1 adopts multilayer vibration screening, and the screen cloth bore of multilayer screening is all inconsistent, and the screen cloth bore of multilayer screening reduces in proper order from inside to outside.
4. The traditional Chinese medicine formula for treating diabetes according to claim 1, which is characterized in that: when the medicine is prepared in the step S3, the fine particle powder needs to be weighed when the fine particle powder is added, the mass ratio of the added fine particle powder to the added water is 1:3, when the water is used as a solvent, the medicine needs to be added for three times, hot water needs to be added for the first time and stirred, the dissolution of the fine particle powder is quickened, warm water is added for the second time and stirred, the prepared medicine is diluted, and a normal-temperature aqueous solution is added for the third time, so that the dissolution efficiency of the medicine is improved.
5. The traditional Chinese medicine formula for treating diabetes according to claim 1, which is characterized in that: when the medicament is prepared in the step S3, after the solution starts to boil, maintaining the temperature and stirring, controlling the duration to be 15-20 min, adding granulated sugar into the boiled solution, and increasing the sweetness of the solution.
6. The traditional Chinese medicine formula for treating diabetes according to claim 5, which is characterized in that: and (3) concentrating and filtering the S4, bottling the solution, and wrapping a hydrophobic film coating on the inner wall of a bottling container, wherein the hydrophobic film coating consists of alkyl cellulose, vinyl acetic acid polymeric derivatives, stearic acid film coating liquid and white wax oil.
7. The traditional Chinese medicine formula for treating diabetes according to claim 1, which is characterized in that: the method comprises the steps of (1) crushing medicinal materials, wherein the prepared medicinal materials are in parts by weight: 15 parts of baical skullcap root, 10 parts of coptis root, 20 parts of Indian buead, 18 parts of cassia bark, 10 parts of astragalus root, 8 parts of leech, 10 parts of Heishan tablet, 12 parts of rhubarb, 15 parts of largehead atractylodes rhizome, 16 parts of gorgon euryale seed, 12 parts of dried ginger and 15 parts of honey-fried licorice root.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310102011.XA CN116270950A (en) | 2023-02-13 | 2023-02-13 | Traditional Chinese medicine formula for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310102011.XA CN116270950A (en) | 2023-02-13 | 2023-02-13 | Traditional Chinese medicine formula for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116270950A true CN116270950A (en) | 2023-06-23 |
Family
ID=86789719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310102011.XA Pending CN116270950A (en) | 2023-02-13 | 2023-02-13 | Traditional Chinese medicine formula for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116270950A (en) |
-
2023
- 2023-02-13 CN CN202310102011.XA patent/CN116270950A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101948376B (en) | Rapid extraction and separation method of paeonolum | |
| CN103285305B (en) | Preparation method of prepared rehmannia root decoction piece | |
| CN101284120A (en) | Process for preparing Pingxiao preparation | |
| CN108126026B (en) | Preparation method of cordyceps sinensis, astragalus and ginseng capsules | |
| CN101199812B (en) | Chinese medicine granules for treating heart function exhaustion, producing method and quality controlling method thereof | |
| CN116270950A (en) | Traditional Chinese medicine formula for treating diabetes | |
| CN108295147A (en) | A kind of process of preparing of RUPIXIAO TIEGAO medicinal extract | |
| CN101472600B (en) | Medicament composition for regulating blood sugar and blood fat as well as preparation method and application thereof | |
| CN109556352B (en) | Drying method of traditional Chinese medicine fluid extract | |
| CN105902502B (en) | A kind of dracocephalum heterophyllum particle electuary and preparation method thereof | |
| CN115414440A (en) | A decoction of radix rehmanniae Preparata and radix rehmanniae Preparata, its preparation method, and quality control standard | |
| CN104983805A (en) | Preparation method of Pudilan anti-inflammatory tablet | |
| CN109569019A (en) | A kind of automation extraction separation method of starch Chinese medicine | |
| CN108553632A (en) | A kind of preparation method of the hot compound fresh bamboo juice of clearing lung-heat | |
| CN104274580A (en) | Traditional Chinese medicinal composition and its discriminating method | |
| CN106728081B (en) | Preparation method of capsule for clearing away turbid and tonifying kidney | |
| CN100457151C (en) | Chinese goldthread soft capsule for clearing away adverse lung energy and its prepn process | |
| CN1695713B (en) | Medication for treating diabetes and preparation method and quality control method | |
| CN1537545A (en) | Sugar-free type blood-fat-lowering granule, and its prepn. method | |
| CN105080180A (en) | Horizontal medical material extraction device | |
| CN111166858A (en) | Preparation method of stomach harmonizing granules | |
| CN109820982A (en) | A kind of preparation process of Yunkang oral liquid | |
| CN113546049B (en) | Flexible pill medicine adhesive and flexible pill prepared by using same | |
| CN103877171A (en) | Preparation process for liver-protecting tablet | |
| CN116036144B (en) | Preparation method of water-soluble liver and gall extract powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |